Centrient Pharmaceuticals to boost statins manufacturing capacity
Doubling our API capacity to meet the growing demand
With a dedicated statin production facility in India, Centrient Pharmaceuticals is one of the largest commercial statin producers worldwide today.
As a result of the continued growth of the global atorvastatin and rosuvastatin market and an increased interest in Centrient Pharmaceuticals’ uniquely produced statins, we are proud to announce that we have decided to further expand our API statins facility.
Having broken ground on 28 November, the factory expansion is now officially underway.
With a doubling of the production capacity forthcoming, we are committed to maintain our leadership position and to continue to support our customers now and in the future.
![Centrient Pharmaceuticals](https://www.cphi-online.com/c247415th_S-comp247415.jpg)
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance